Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
latiglutenase (IMGX003) / Entero Therap
NCT04839575: Study of Latiglutenase in T1D/CD Patients	Terminated	2	13	US	Latiglutenase, IMGX003, Placebo	Entero Therapeutics, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Immunogenics, LLC	Celiac Disease	12/22	12/22
NCT04243551: Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients	Terminated	2	84	US	Latiglutenase, IMGX003, Placebo	Entero Therapeutics, National Institute of Allergy and Infectious Diseases (NIAID)	Celiac Disease	10/23	10/23